st33

Spray November 2014

November 2014 Spray 33 Mergers & Acquisitions Merck & Co., Inc. officially completed the transfer of its Consumer Care business to Bayer AG. Pending antitrust approval in Mexico and South Korea, the $14.2 billion acquisition includes Coppertone sun care products, Dr. Scholl’s, Lotrimin, Tinactin and over-the-counter nasal sprays Afrin and Nasonex. Bayer, who announced plans for the purchase in May, sold $7 billion of bonds to fund it. The deal is expected to make Bayer the second largest non-prescription pharmaceutical business in the world, ahead of Johnson & Johnson and behind Novartis and GlaxoSmithKline, who recently announced the combining of their over-the-counter operations in a joint venture. Johnson & Johnson (J&J) reached an agreement to purchase Alios BioPharma, Inc., a San Francisco, CA-based biopharmaceutical company that develops antiviral treatments for respiratory diseases. The $1.75 billion sale encompasses BioPharma’s full catalogue of potential viral infection remedies, including AL-8176, an oral therapy in Phase II of development that is designed to treat respiratory syncytial virus (RSV), an infection that affects virtually all children in the U.S. by two years of age, according to the Centers for Disease Control & Prevention (CDC). Aerosol can producer China Aluminum Cans announced its intention to purchase Euro-Asia Group, a conglomeration of aerosol packaging and chemical manufacturers that includes Euro-Asia Aluminum Can Ind. Co. and Botny Chemical Co., Ltd. The acquisition cost HK$900 million ($116 million). Pro Mach, Inc., announced that AEA Investors LP had acquired the packaging machinery producer from The Jordan Co. Among Pro Mach-owned brands are Axon, Brenton, Federal Mfg., Labeling Systems and Zalkin. Univar Inc., struck a deal with Evonik Corp. to market and distribute Evonik personal care products in the Northeastern U.S. While the agreement is exclusive, Evonik will continue to sell its silicone-based ingredients and materials directly. Effective in January, Puma SE announced a licensing agreement with L’Oréal to produce beauty products, including deodorants, body lotions, aftershave and fine fragrance. The deal follows the expiration of Puma’s licensing agreement with Procter & Gamble. Personal care and pharmaceutical packaging firm ILEOS announced plans to merge subsidiary Bioplan, a contract filler with five locations worldwide, with Arcade Marketing, a subsidiary of Visant Corp. The merger is a joint venture between Visant and ILEOS’ owner Oaktree Capital Management. SPRAY


Spray November 2014
To see the actual publication please follow the link above